Ellipsis Health uses voice biomarkers to measure and manage mental health conditions such as stress, depression, and anxiety symptoms. The platform produces an assessment of a person’s mental health based on their speech, to support clinical decisions.
The company's proprietary platform uses deep learning algorithms to analyze short voice samples, creating an objective and scalable clinical decision support tool. Ellipsis Health's technology identifies and measures the severity of stress, anxiety, and depression by examining both the content of what a person says and how they say it. The company's solution integrates with existing healthcare systems and workflows, allowing providers to screen patients, check care needs between sessions, inform treatment plans, and monitor results. Ellipsis Health's database includes clinically labeled recordings from over 100,000 individuals representing diverse demographics.
Key customers and partnerships
In August 2022, the company partnered with Ceras Health to use biomarkers derived from patients’ voices for mental health care on Ceras’ platform. Other customers include Desert Oasis Healthcare and Augmedix. Ellipsis Health has also partnered with Cigna Healthcare International since 2021 on a publicly available tool called StressWaves, which uses voice and AI to screen for stress levels and connect users to appropriate resources.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.